Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lybridos food effect pharmacokinetic study
NL-OMON41098Not yet recruiting
- Sponsor
- FSD Pharma
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Lybridos and buspirone in female sexual dysfunction (FSD) (2 arms), sponsored by FSD Pharma. Primary endpoints: AUC0-inf ratio fed versus fasted and Cmax ratio fed versus fasted. Planned start Jan 2015; status: not yet recruiting.
02
Drugs
Lybridosbuspirone
03
Conditions
female sexual dysfunction (FSD)
Beyond the preview
Go deeper on NL-OMON41098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41098.